Megan Aleardi
Overview
Explore the profile of Megan Aleardi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
1015
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Makris N, Seidman L, Brown A, Valera E, Kaiser J, Petty C, et al.
Psychiatry Res
. 2012 May;
202(1):1-11.
PMID: 22640688
Although Attention-Deficit/Hyperactivity Disorder (ADHD) and Bipolar Disorder (BPD) frequently co-occur and represent a particularly morbid clinical form of both disorders, neuroimaging research addressing this comorbidity is scarce. Our aim was...
2.
Brown A, Biederman J, Valera E, Lomedico A, Aleardi M, Makris N, et al.
J Psychiatr Res
. 2012 Jan;
46(4):476-83.
PMID: 22272986
Attention-Deficit/Hyperactivity Disorder (ADHD) and Bipolar Disorder (BPD) co-occur frequently and represent a particularly morbid clinical form of both disorders, however underlying neural circuitry contributing to the comorbidity remain understudied. Our...
3.
Akinkuolie A, Aleardi M, Ashaye A, Gaziano J, Djousse L
Am J Cardiol
. 2012 Jan;
109(7):994-7.
PMID: 22221952
Although previous studies have reported an association between height and cardiovascular disease, it is unclear whether height is associated with the risk of heart failure (HF). We hypothesized that height...
4.
Spencer T, Mick E, Surman C, Hammerness P, Doyle R, Aleardi M, et al.
J Atten Disord
. 2010 May;
15(4):286-94.
PMID: 20495161
Objective: The main aim of this study was to examine the efficacy, tolerability, and compliance of an extended-release formulation of methylphenidate (OROS-MPH) in adults with ADHD receiving immediate-release methylphenidate (IR-MPH)....
5.
Joshi G, Wozniak J, Mick E, Doyle R, Hammerness P, Georgiopoulos A, et al.
J Child Adolesc Psychopharmacol
. 2010 Feb;
20(1):7-14.
PMID: 20166791
Objective: The aim of this study was to evaluate the safety and efficacy of extended release carbamazepine (CBZ-ER) monotherapy in the treatment of pediatric bipolar disorder (BD). Method: This was...
6.
Biederman J, Hammerness P, Doyle R, Joshi G, Aleardi M, Mick E
Neuropsychiatr Dis Treat
. 2008 Aug;
4(1):203-7.
PMID: 18728799
Objective: Children and adolescents with bipolar disorder are also at high risk of having comorbid attention-deficit hyperactivity disorder (ADHD). The objective of this study was to estimate improvement in ADHD...
7.
Bush G, Spencer T, Holmes J, Shin L, Valera E, Seidman L, et al.
Arch Gen Psychiatry
. 2008 Jan;
65(1):102-14.
PMID: 18180434
Context: Previous studies have reported hypofunction, structural abnormalities, and biochemical abnormalities of the dorsal anterior midcingulate cortex (daMCC) in attention-deficit/hyperactivity disorder (ADHD). Stimulant medications are effective treatments for ADHD, but...
8.
Biederman J, Mick E, Spencer T, Dougherty M, Aleardi M, Wozniak J
Bipolar Disord
. 2007 Dec;
9(8):888-94.
PMID: 18076539
Objective: To assess the effectiveness and tolerability of ziprasidone for treating pediatric mania. Methods: This was an eight-week, open-label, prospective study of ziprasidone monotherapy (57.3 +/- 33.9 mg/day) in 21...
9.
Biederman J, Mick E, Spencer T, Doyle R, Joshi G, Hammerness P, et al.
CNS Spectr
. 2007 Sep;
12(9):683-9.
PMID: 17805214
Introduction: Aripiprazole is a novel second-generation antipsychotic approved for the treatment of bipolar disorder in adults but there is no systematic data available in pediatric bipolar disorder. Methods: This was...
10.
Faraone S, Biederman J, Spencer T, Aleardi M
MedGenMed
. 2007 Apr;
8(4):4.
PMID: 17415287
Objective: Medications used to treat attention-deficit/hyperactivity disorder (ADHD) have been well researched, but comparisons among drugs are hindered by the absence of direct comparative trials. Methods: We analyzed recent published...